Patents by Inventor Donald L. Wassom

Donald L. Wassom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method to detect IgE
    Patent number: 7691384
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc68 R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: April 6, 2010
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Method to detect IgE
    Patent number: 7195767
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc?R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: March 27, 2007
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Method to detect IgE
    Publication number: 20040214209
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat dog, horse or mouse. The present invention also relates to kits to perform such methods.
    Type: Application
    Filed: January 23, 2004
    Publication date: October 28, 2004
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Method to detect IgE
    Patent number: 6682894
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: January 27, 2004
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Method to detect IgE
    Publication number: 20020034771
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Application
    Filed: August 30, 2001
    Publication date: March 21, 2002
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Method to detect IgE
    Patent number: 6309832
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: March 31, 1999
    Date of Patent: October 30, 2001
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Feline Fc epsilon receptor alpha chain nucleic acid molecules
    Patent number: 6284881
    Abstract: The present invention relates to feline Fc epsilon receptor alpha chain nucleic acid molecules, compositions comprising such nucleic acid molecules, and methods to use such nucleic acid molecules to produce feline Fc epsilon receptor alpha chain proteins.
    Type: Grant
    Filed: February 29, 2000
    Date of Patent: September 4, 2001
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom, Eric R. Weber
  • Feline Fc epsilon receptor alpha chain nucleic acid molecules, and uses thereof
    Patent number: 6103494
    Abstract: The present invention relates to feline Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: August 15, 2000
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom, Eric R. Weber
  • Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
    Patent number: 5958880
    Abstract: The present invention relates to feline Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: September 28, 1999
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom, Eric R. Weber
  • Method to detect IgE
    Patent number: 5945294
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc.sub..epsilon. R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: November 26, 1996
    Date of Patent: August 31, 1999
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Carbohydrate-based vaccine and diagnostic reagent for trichinosis
    Patent number: 5707817
    Abstract: The present invention relates to Trichinella diagnostic reagents that include a .beta.-tyvelose-containing composition and use of such reagents to detect Trichinella, and particularly Trichinella spiralis infections. The present invention also includes diagnostic kits based on such reagents and therapeutic agents based on the the knowledge that .beta.-tyvelose is produced by Trichinella spiralis parasites.
    Type: Grant
    Filed: March 31, 1995
    Date of Patent: January 13, 1998
    Assignee: Colorado State University Research Foundation
    Inventors: Nancy Wisnewski, Robert B. Grieve, Donald L. Wassom, Michael R. McNeil
  • Carbohydrate-based vaccine and diagnostic reagent for trichinosis
    Patent number: 5686256
    Abstract: The present invention relates to Trichinella diagnostic reagents that include at least one tyvelose-containing oligosaccharide, or functional equivalent thereof, and use of such reagents to detect Trichinella, and particularly Trichinella spiralis infections. The present invention also includes diagnostic kits based on such reagents and anti-Trichinella spiralis drugs based on the knowledge that tyvelose is produced by Trichinella spiralis parasites.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: November 11, 1997
    Assignee: Colorado State University Research Foundation
    Inventors: Nancy Wisnewski, Robert B. Grieve, Donald L. Wassom, Michael R. McNeil
  • Carbohydrate-based vaccine and diagnostic reagent for trichinosis
    Patent number: 5541075
    Abstract: The present invention relates to Trichinella vaccines that include at least one tyvelose-containing oligosaccharide or functional equivalent thereof, to Trichinella vaccines that include at least one fucose-containing oligosaccharide or functional equivalent thereof, and to the use of such vaccines to protect animals from Trichinella infections, and particularly from trichinosis caused by Trichinella spiralis infection. Such vaccines can also be used to produce antibodies that are capable of protecting an animal from Trichinella infections and of diagnosing such infections. The present invention also relates to Trichinella diagnostic reagents that include at least one tyvelose-containing oligosaccharide, or functional equivalent thereof, and use of such reagents to detect Trichinella, and particularly Trichinella spiralis infections.
    Type: Grant
    Filed: February 5, 1993
    Date of Patent: July 30, 1996
    Assignee: Heska Corporation
    Inventors: Nancy Wisnewski, Robert B. Grieve, Donald L. Wassom, Michael R. McNeil